By regulating Pten mRNA for m6A modification via a YTHDF1-dependent mechanism, the downregulation of METTL14 in RCC inhibited Pten expression, leading to the progression of tumours through PI3K/AKT signaling. Here, METTL14 is linked to renal cell adenocarcinoma.